These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 22291913)

  • 21. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo.
    Hermankova M; Siliciano JD; Zhou Y; Monie D; Chadwick K; Margolick JB; Quinn TC; Siliciano RF
    J Virol; 2003 Jul; 77(13):7383-92. PubMed ID: 12805437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.
    Persaud D; Pierson T; Ruff C; Finzi D; Chadwick KR; Margolick JB; Ruff A; Hutton N; Ray S; Siliciano RF
    J Clin Invest; 2000 Apr; 105(7):995-1003. PubMed ID: 10749578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
    Chun TW; Carruth L; Finzi D; Shen X; DiGiuseppe JA; Taylor H; Hermankova M; Chadwick K; Margolick J; Quinn TC; Kuo YH; Brookmeyer R; Zeiger MA; Barditch-Crovo P; Siliciano RF
    Nature; 1997 May; 387(6629):183-8. PubMed ID: 9144289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation into an Effector Memory Phenotype Potentiates HIV-1 Latency Reversal in CD4
    Kulpa DA; Talla A; Brehm JH; Ribeiro SP; Yuan S; Bebin-Blackwell AG; Miller M; Barnard R; Deeks SG; Hazuda D; Chomont N; Sékaly RP
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients.
    Spina CA; Anderson J; Archin NM; Bosque A; Chan J; Famiglietti M; Greene WC; Kashuba A; Lewin SR; Margolis DM; Mau M; Ruelas D; Saleh S; Shirakawa K; Siliciano RF; Singhania A; Soto PC; Terry VH; Verdin E; Woelk C; Wooden S; Xing S; Planelles V
    PLoS Pathog; 2013; 9(12):e1003834. PubMed ID: 24385908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-HIV-1 ADCC and HIV-1 Env Can Be Partners in Reducing Latent HIV Reservoir.
    Suryawanshi P; Bagul R; Shete A; Thakar M
    Front Immunol; 2021; 12():663919. PubMed ID: 33995393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals.
    Wonderlich ER; Subramanian K; Cox B; Wiegand A; Lackman-Smith C; Bale MJ; Stone M; Hoh R; Kearney MF; Maldarelli F; Deeks SG; Busch MP; Ptak RG; Kulpa DA
    PLoS Pathog; 2019 Oct; 15(10):e1008074. PubMed ID: 31609991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of HIV-1 latency in an ex vivo model that uses primary central memory T cells.
    Bosque A; Planelles V
    Methods; 2011 Jan; 53(1):54-61. PubMed ID: 20970502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals.
    Siliciano JD; Siliciano RF
    Methods Mol Biol; 2005; 304():3-15. PubMed ID: 16061962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses.
    Descours B; Petitjean G; López-Zaragoza JL; Bruel T; Raffel R; Psomas C; Reynes J; Lacabaratz C; Levy Y; Schwartz O; Lelievre JD; Benkirane M
    Nature; 2017 Mar; 543(7646):564-567. PubMed ID: 28297712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IP-10 Promotes Latent HIV Infection in Resting Memory CD4
    Wang Z; Yin X; Ma M; Ge H; Lang B; Sun H; He S; Fu Y; Sun Y; Yu X; Zhang Z; Cui H; Han X; Xu J; Ding H; Chu Z; Shang H; Wu Y; Jiang Y
    Front Immunol; 2021; 12():656663. PubMed ID: 34447368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infection.
    Mann JFS; Pankrac J; Klein K; McKay PF; King DFL; Gibson R; Wijewardhana CN; Pawa R; Meyerowitz J; Gao Y; Canaday DH; Avino M; Poon AFY; Foster C; Fidler S; Shattock RJ; Arts EJ
    EBioMedicine; 2020 Sep; 59():102853. PubMed ID: 32654992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
    Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
    mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The multifaceted nature of HIV latency.
    Dufour C; Gantner P; Fromentin R; Chomont N
    J Clin Invest; 2020 Jul; 130(7):3381-3390. PubMed ID: 32609095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of a Novel Humanized Mouse Model To Investigate
    Flerin NC; Bardhi A; Zheng JH; Korom M; Folkvord J; Kovacs C; Benko E; Truong R; Mota T; Connick E; Jones RB; Lynch RM; Goldstein H
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD161
    Li X; Liu Z; Li Q; Hu R; Zhao L; Yang Y; Zhao J; Huang Z; Gao H; Li L; Cai W; Deng K
    mBio; 2019 Oct; 10(5):. PubMed ID: 31594817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Entry of Polarized Effector Cells into Quiescence Forces HIV Latency.
    Dobrowolski C; Valadkhan S; Graham AC; Shukla M; Ciuffi A; Telenti A; Karn J
    mBio; 2019 Mar; 10(2):. PubMed ID: 30914509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A CCR5
    Terahara K; Iwabuchi R; Hosokawa M; Nishikawa Y; Takeyama H; Takahashi Y; Tsunetsugu-Yokota Y
    BMC Res Notes; 2019 Apr; 12(1):242. PubMed ID: 31036079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enumeration of latently infected CD4+ T cells from HIV-1-infected patients using an HIV-1 antigen ELISPOT assay.
    Fondere JM; Planas JF; Huguet MF; Baillat V; Bolos F; Reynes J; Vendrell JP
    J Clin Virol; 2004 Jan; 29(1):33-8. PubMed ID: 14675867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.